Low incidence of candidaemia among neutropenic patients treated for haematological diseases

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 489-493

  Chryssanthou, Erja ^a,b   Kalin, Mats ^a   Engervall, Per ^a   Petrini, Björn ^a   Bjorkholm, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLOSIS; BLOOD CULTURE; BLOOD DISEASE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA TROPICALIS; CANDIDIASIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CANDIDIASIS; FEMALE; FUNGEMIA; HEMATOLOGIC DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES;

EID: 0032411558     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161502     Document Type: Article

References (36)

1. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
2. Voss A, Kluytmans JA, Koeleman JG, Spanjaard L, Vandenbroucke-Grauls CM, Verbrugh HA, Vos MC, Weerink AY, Hoogkamp-Korstanje JA, Meis JF. Occurrence of yeast blood-stream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 909-12.
3. Voss A, le Noble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25: 8-11.
4. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
5. Bruun B, Westh H, Stenderup J. Fungemia: an increasing problem in a Danish university hospital 1989 to 1994. J Clin Microbiol Infect 1995; 1: 124-6.
6. Debusk CH, Daoud R, Thirumoorthi MC, Wilson FM, Khatib R. Candidemia: current epidemiologic characteristics and a long-term follow-up of the survivors. Scand J Infect Dis 1994; 26: 697-703.
7. Simmons BP, Gelfand MS, Kritchevsky SB, Greene W, Chow S. Decrease in Candidemia rates associated with empiric use of amphotericin B and fluconazole for nosocomial fever of unknown origin. Infect Dis Clin Pract 1997; 6: 177-81.
8. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-30.
9. Giamarellou H, Antoniadou A. Epidemiology, diagnosis, and therapy of fungal infections in surgery. Infect Contr Hosp Epidemiol 1996; 17: 558-64.
10. Kralovicova K, Spanik S, Oravcova E, Mrazova M, Morova E, Gulikova V, Kukuckova E, Koren P, Pichna P, Nogova J, Kunova A, Trupl J, Krcmery V. Fungemia in cancer patients undergoing chemotherapy versus surgery - risk factors, etiology and outcome. Scand J Infect Dis 1997; 29: 301-4.
11. Chubachi A, Miura I, Ohshima A, Nishinari T, Nimura T, Niitsu H, Miura AB. Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment. Am J Med Sci 1994; 308: 309-12.
12. Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996; 22 (Suppl 2): S73-88.
13. Bernhardt H, Knoke M. Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol Suppl 1997; 222: 102-6.
14. Barnett JA, Payne RW, Yarrow D. Yeasts: characteristics and identification. Cambridge: Cambridge University Press, 1990.
15. De Hoog GS, Guarro J. Atlas of clinical fungi. Baarn and Delft: Centraalbureau voor Schimmelcultures, 1995.
16. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired Candidemia. A matched case-control study. Arch Intern Med 1989; 149: 2349-53.
17. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and Candidemia in neutropenic patients. J Clin Microbiol 1994; 32: 975-80.
18. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-8.
19. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization of nosocomial Candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733-8.
20. Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F. Candida colonization and systemic infection in neutropenic patients. Cancer 1989; 64: 2030-4.
21. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994; 18: 525-32.
22. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of antileukemic regimen. Clin Infect Dis 1995; 21: 361-9.
23. Denning DW, Evans EGV, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. Eur J Clin Microbiol Infect Dis 1997; 16: 424-36.
24. Creger RJ, Weeman KE, Jacobs MR, Morrissey A, Parker P, Fox RM, Lazarus HM. Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J Clin Microbiol 1998; 36: 290-3.
25. Lyon R, Woods G. Comparison of the BacT/Alert and Isolator blood culture systems for recovery of fungi. Am J Clin Pathol 1995; 103: 660-2.
26. Weinstein MP, Mirrett S, Reimer LG, Wilson ML, Smith-Elekes S, Chirard CR, Reller LB. Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol 1995; 33: 978-81.
27. Björkholm M. Prophylaxis of fungal infections in neutropenic patients. Meeting of the Expert Sessions of the Second EHA, 1996; 14-9.
28. Gøtzsche PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated neutropenia. BMJ 1997; 314: 1238-44.
29. Van Delden C, Lew DP, Chapius B, Rohner P, Hirschel B. Antifungal prophylaxis in severely neutropenic patients: how much fluconazole is necessary? J Clin Microbiol Infect 1995; 1: 24-30.
30. Uzun O, Anaissie EJ. Problems and controversies in the management of hematogenous candidiasis. Clin Infect Dis 1996; 22 (Suppl 2): S95-101.
31. Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G, for the Multicentre Study Group. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. J Antimicrob Chemother 1993; 31: 973-84.
32. Occhipinti DJ, Gubbins PO, Schreckenberger P, Danziger LH. Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria. Eur J Clin Microbiol Infect Dis 1994; 13: 459-67.
33. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-72.
34. Denning DW. Aspergillosis: diagnosis and treatment. Int J Antimicrob Agents 1996; 6: 161-8.
35. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991; 13: 211-5.
36. Bergmann OJ, Mogensen SC, Ellermann-Eriksen S, Ellegaard J. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 1997; 15: 2269-74.